Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Classical hematology 1

Conditions

Neoplasms 5Anemia 5Prostatic Neoplasms 1Pleural Effusion, Malignant 1Pleural Effusion 1Myelodysplastic Syndromes 1Lung Neoplasms 1Leukemia 1Fatigue 1Critical Illness 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

talimogene laherparepvec 1rilotumumab 1lipoplatin 1ganitumab 1cediranib 1Zoledronic Acid 1Verteporfin 1Thoracentesis 1Therapeutics 1Talc 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Spectrum Analysis 1Sodium Chloride 1SPI-77, liposomal 1Radiotherapy, Conformal 1Photochemotherapy 1Nivolumab 1Naproxen 1Immunohistochemistry 1Fluorodeoxyglucose F18 1Fentanyl 1Etoposide 1Drug Therapy 1Doxycycline 1Dihematoporphyrin Ether 1Darbepoetin alfa 1Coal Tar 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Pleural Effusion, Malignant × Darbepoetin alfa × Clear all
NCT00858364 2022-11-30

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Amgen

Phase 3 Terminated
2,549 enrolled 19 charts
Classical hematologyThoracic

Anemia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Pleural Effusion, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡